ArticleAmerican journal of cancer research2013

Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma.

Christina A von Roemeling et al.PubMed ↗Full text ↗

No numbers read from the abstract.